CARLSBAD, CA — International Stem Cell Corporation (OTCQB: ISCO) (www.internationalstemcell.com) (“ISCO” or “the Company”), a California-based biotechnology company focused on therapeutic and research products, today announced that its subsidiary, Lifeline Cell Technology, has expanded its sales network by adding a number of new distributors in Asia and Oceania. “Expanding our footprint in the fast-growing Asian […]
Regensburg, Germany -– Lophius Biosciences GmbH, a privately held biotech company focusing on the development and marketing of innovative T cell based research tools and diagnostic systems for functional assessment of pathogen/disease-reactive T cells, today announced the launch of its new T CELL TOOLS product line together with its new e-commerce online order portal. The […]
NEWARK, Calif. — StemCells, Inc. (Nasdaq:STEM), today announced its intent to offer and sell 11,299,435 shares of common stock and short term warrants for the purchase of up to 9,604,520 additional shares of common stock to two well recognized institutional biotechnology investors, subject to market and other conditions, for gross proceeds of $20 million, before […]
LAWRENCEVILLE, N.J. — Celsion Corporation (NASDAQ: CLSN), a leading oncology drug development company, today announced initiation of sales of its proprietary reagent products for life science research. Celsion’s reagent products are based on its newly acquired proprietary delivery platform technologies, TheraPlas™ and TheraSilence™. TheraPlas™ and TheraSilence™ are designed for optimal transfection (intra-cellular delivery) of plasmid […]
GERMANTOWN, Maryland, and HILDEN, Germany -— QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced the launch of 14 new GeneReadTM DNAseq V2 gene panels targeting an extensive range of cancer-related genes or gene regions. Gene panels are an integral part of many next-generation sequencing (NGS) workflows. They are used to enrich genes of […]
Toronto, Ontario — SQI Diagnostics Inc. (TSX-V: SQD),a life sciences company that develops and commercializes proprietary technologies and products for advanced microarray diagnostics, today announced it has appointed Dr. Allan Pronovost to its Board of Directors. SQI will also retain the services of Dr. Pronovost, as strategic advisor, where he will assist the Company in […]
Ebersberg — Eurofins Genomics, international market leader in genomic services, has signed a two year contract with Lund University as one of several preferred suppliers for oligonucleotides on the recently awarded framework contract. The contract builds on a long standing relationship and offers best oligonucleotide prices to Lund University, Gothenburg University, Linköping University and Chalmers […]
BEVERLY, Mass. — RAN Biotechnologies, https://www.ranbiotechnologies.com, a provider of chemicals and solutions specially optimized for biotechnological applications, has entered into a distributorship agreement with Fluigent, https://www.fluigent.com, a Paris-based leader in microfluidic flow control instruments, for distribution of RAN Biotechnologies products in Europe. “We are very excited to be distributing the products of RAN Biotechnologies,” said […]
San Francisco, CA — Synthetic biology company Pareto Biotechnologies today announces a technology partnership with global bioengineering leader DNA2.0, enabling Pareto to further develop its technology for quick-to-market products. The integration of Pareto’s rational-based design approach and DNA2.0’s machine learning optimization technologies, such as ProteinGPS™ and GeneGPS™, is drastically speeding up the process of engineering […]
ALAMEDA, Calif.– BioTime, Inc. (NYSE MKT:BTX) announced today the issuance of 14 new patents to BioTime and its subsidiary companies. The patents issued in Australia, Canada, China, Japan, and the United States, cover a wide range of core technologies foundational to BioTime’s businesses. The new patents add to the largest known patent estate under one […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
